Image source: The Motley Fool. DATE Thursday, Aug. 13, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Interim CFO, VP Accounting and Finance - Henry Du Chief Executive Officer - Michael E. McFadden Chief Operating Officer - Lauren D'Angelo Full Co…
Key Points Interested in Alpha Cognition Inc.? Here are five stocks we like better. ZUNVEYL demand accelerated: Second-quarter product revenue rose 71% sequentially to approximately $6 million, supported by a 37% increase in bottles sold,…
Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Surpass Estimates
Halozyme Therapeutics (HALO) came out with quarterly earnings of $2.28 per share, beating the Zacks Consensus Estimate of $1.82 per share. This compares to earnings of $1.54 per share a year ago. These figures are adjusted for non-recurrin…
Alpha Cognition Inc. (ACOG) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Alpha Cognition Inc. (ACOG) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's ea…
Global Partners Gears Up for Q2 Earnings: What's in the Cards?
Global Partners LP GLP is set to release second-quarter 2026 results on Aug. 7. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a profit of $1.24 per share on revenues of $7.5 billion. Let's delve into the factors…
Agios Pharmaceuticals (AGIO) came out with a quarterly loss of $1.69 per share versus the Zacks Consensus Estimate of a loss of $1.86. This compares to a loss of $1.93 per share a year ago. These figures are adjusted for non-recurring item…
Alpha Cognition Inc. (ACOG) Surges 8.6%: Is This an Indication of Further Gains?
Alpha Cognition Inc. (ACOG) shares ended the last trading session 8.6% higher at $8.58. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 21.5% gai…
Time to Jump In? Raymond James Is Bullish on These 2 Stocks
Geopolitics have been making headlines again – war in the Middle East and uncertainty in the price of oil are stirring up the headwinds. Yet, the S&P 500 has remained resilient, supported by strong corporate earnings. During the first-quar…
Raymond James Starts Alpha Cognition (ACOG) at Outperform
Alpha Cognition Inc. (NASDAQ:ACOG) is one of the 10 High Growth Stocks Insiders Are Buying. On July 10, 2026, Raymond James analyst Ryan Deschner initiated coverage of Alpha Cognition Inc. (NASDAQ:ACOG) with an Outperform rating and $20 pr…
These low-priced stocks are flashing overbought signals
[Wall Street sign, New York City, USA] mbbirdy/E+ via Getty Images Stocks trading below $10 often attract retail investors looking for high-growth opportunities at relatively low entry prices. However, many of these low-priced equities can…
Key Points Interested in Alpha Cognition Inc.? Here are five stocks we like better. ZUNVEYL sales and adoption continued to accelerate in Q1 2026, with net product revenue rising to $3.5 million from $2.5 million in Q4 2025 and bottles dis…
Image source: The Motley Fool. DATE Thursday, March 26, 2026 at 12 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Michael McFadden Chief Operating Officer — Lauren D’Angelo Chief Financial Officer — Henry Du Need a quote from a Motley…
Alpha Cognition logo Key Points Alpha Cognition reported Q4 total revenue of $2.8M (including $2.5M in net ZUNVEYL sales) with 4,941 bottles dispensed in Q4 and management highlighting strong adoption in long-term care—bottles dispensed gr…
After-Hours Earnings Report for March 26, 2026 : AGX, OXM, VERI, BAK, ACOG, RANI, SLND, VTSI, WPRT, LSF, XOS, DARE
The following companies are expected to report earnings after hours on 03/26/2026. Visit our Earnings Calendar for a full list of expected earnings releases. Argan, Inc. (AGX)is reporting for the quarter ending January 31, 2026. The buildi…
Water Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This Year
Key Points Solas Capital Management added 460,619 shares of PRMB in the fourth quarter. The quarter-end position value increased by $7.53 million as a result. PRMB now accounts for 4.27% of fund AUM.10 stocks we like better than Primo Bran…
Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue
Key Points Solas Capital Management acquired 73,494 shares of Euronet Worldwide in the fourth quarter. The quarter-end position value increased by $5.59 million as a result of the new position. The new holding represents 3.17% of fund AUM,…
Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue
On February 17, 2026, Solas Capital Management disclosed a new position in Euronet Worldwide(NASDAQ:EEFT), acquiring 73,494 shares in the fourth quarter. The shares were worth $5.59 million at quarter’s end. What happened According to a Se…
Solas Capital Loads Up On Kyndryl With 407,000 Shares Bought
On February 17, 2026, Solas Capital Management, LLC disclosed a new position in Kyndryl(NYSE:KD). What happened According to a Securities and Exchange Commission (SEC) filing dated February 17, 2026, Solas Capital Management, LLC initiated…
MDT Q2 Earnings Preview: Cardiovascular Unit Likely to Boost Growth
Medtronic MDT is set to release second-quarter fiscal 2026 results on Nov. 18, before the market opens. The MedTech giant posted earnings per share (EPS) of $1.26 in the last reported quarter, which surpassed the Zacks Consensus Estimate b…
Alpha Cognition prices $35M public offering of common shares
* Alpha Cognition (NASDAQ:ACOG [https://seekingalpha.com/symbol/ACOG]) has priced its underwritten public offering of 5.6M common shares (or pre-funded warrants in lieu thereof), at $6.25 per share for gross proceeds of $35.0 million. * Th…
Alpha Cognition enters $75 million at-the-market offering agreement with Wainwright
Alpha Cognition Inc. (NASDAQ:ACOG) announced Friday that it has entered into an At the Market Offering Agreement with H.C. Wainwright & Co., LLC to offer and sell common shares with an aggregate gross sales value of up to $75 million. The…
Alpha Cognition Announces Partner China Medical System Has NDA Accepted in China for the Review of ZUNVEYL® (Benzgalantamine) for Alzheimer’s Disease
VANCOUVER, British Columbia & DALLAS, July 29, 2025--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition" [ACI], or the "Company"), a biopharmaceutical company developing novel therapies for debilitating neurodegenerativ…
H.C. Wainwright reiterates Buy rating on Alpha Cognition stock, citing promising mTBI data
Investing.com - H.C. Wainwright has maintained its Buy rating and $20.00 price target on Alpha Cognition Inc (NASDAQ:ACOG), representing an 87% upside from the current price of $10.69. The stock has shown strong momentum, gaining 16% in th…
Alpha Cognition files prospectus for resale of 2.38M common shares
* Alpha Cognition (NASDAQ:ACOG [https://seekingalpha.com/symbol/ACOG]) filed a prospectus for the resale of up to 2.38M common shares by selling stockholders. * Alpha Cognition will not receive proceeds from the resale of shares by stockho…
Is Alpha Cognition Inc. (ACOG) Outperforming Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Alpha Cognition Inc. (ACOG) one of those stocks right now? By taking a look at the stock's year-to-d…
Alpha Cognition Inc. Common Stock (ACOG): A Bull Case Theory
We came across a bullish thesis on Alpha Cognition Inc. Common Stock (ACOG) by anygal on r/investing on Reddit. In this article, we will summarize the bulls’ thesis on ACOG. Alpha Cognition Inc. Common Stock (ACOG)'s share was trading at $…
Alpha Cognition Inks $44 Million Licensing Pact For Its Alzheimer's Drug In China
Alpha Cognition Inks $44 Million Licensing Pact For Its Alzheimer's Drug In China On Wednesday, Alpha Cognition Inc. (NASDAQ:ACOG) and China Medical System Holdings Limited announced an exclusive licensing agreement for the development, ma…